New risk tool aims to take the guesswork out of sarcoma treatment choices

NCT ID NCT05741944

Ongoing Knowledge-focused Sponsor: Leiden University Medical Center Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tests a tool called PERSARC that gives soft-tissue sarcoma patients personalized information about the risks and benefits of different treatment options. 120 adults with high-grade sarcoma in their arms or legs will either get standard care or care using PERSARC. The goal is to see if the tool helps patients feel more informed and less conflicted about their treatment decisions.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: PERSARC risk prediction tool
What this could lead to: If successful, this tool could help patients and doctors make clearer, more personalized treatment decisions for soft-tissue sarcoma.
What could go wrong: This is a small, early-stage study focused on decision-making, not on curing or treating the cancer itself. The tool may not improve outcomes or be widely adopted.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PREDICTIVE CANCER MODEL are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

sarcoma soft tissue sarcoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PREDICTIVE CANCER MODEL SOFT TISSUE SARCOMA

Contacts and locations

Locations

Erasmus MC

Rotterdam, South Holland, 3015GD, Netherlands
Leiden University Medical Center

Leiden, South Holland, 2333ZA, Netherlands
Maastricht UMC

Maastricht, Limburg, 6229HX, Netherlands
Netherlands Cancer Institue

Amsterdam, North Holland, 1066CX, Netherlands
Radboud UMC

Nijmegen, Gelderland, 6525GA, Netherlands
UMC Groningen

Groningen, Provincie Groningen, 9713GZ, Netherlands
UMC Utrecht

Utrecht, Utrecht, 3584CX, Netherlands

More trials for these conditions

Other studies related to the condition(s) this trial covers.